Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18285548 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Maribavir for Prevention of CMV After Stem Cell Transplants
Condition: Cytomegalovirus Infection
Intervention: Drug: maribavir

Indicates status has not been verified in more than two years